Código QR (código de barras bidimensional)

Guidance for Canadian Breast Cancer Practice: National Consensus Recommendations for the Systemic Treatment of Patients with HR+/HER2− Metastatic Breast Cancer 2025

Hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) breast cancer accounts for approximately two-thirds of all breast cancers. The treatment landscape for HR+/HER2− metastatic breast cancer has evolved in recent years, with multiple new therapies demonstrating...

Fuld beskrivelse

Na minha lista:
Principais autores: Katarzyna J. Jerzak, Aalok Kumar, Jean-François Boileau, Nathaniel Bouganim, Christine Brezden-Masley, Jeffrey Q. Cao, David W. Cescon, Stephen Chia, Scott Edwards, Anil Abraham Joy, Kara Laing, Nathalie LeVasseur, Sasha Lupichuk, Sandeep Sehdev, Christine Simmons, Marc Webster, Karen A. Gelmon, Mita Manna, on behalf of patient advocacy, Breast Cancer Canada
Format: Artigo
Sprog:Inglês
Udgivet: MDPI AG 2026-02-01
Serier:Current Oncology
Fag:
HR+ HER2− metastatic
advanced
breast cancer
Canadian consensus recommendations
evidence-based
REAL Alliance
Online adgang:https://www.mdpi.com/1718-7729/33/2/106
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker